对于过度营养引起的β细胞损失,Ppid是必要的
Brittney A Covington1, Zihan Tang1, Lisette A Maddison1
1Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
American journal of physiology. Endocrinology and metabolism
|December 15, 2025
概括
环素D (Ppid) 在2型糖尿病模型中驱动β细胞死亡. 抑制Ppid保护β细胞质量,揭示了T2D治疗的关键目标.
科学领域:
- 内分泌学 在内分泌学.
- 线粒体生物学 线粒体生物学
- 糖尿病研究 糖尿病研究
背景情况:
- 2型糖尿病 (T2D) 的特点是功能性β细胞质量的逐渐丧失.
- 斑马鱼胰岛素耐药模型 (zMIR) 的过度营养会诱导小岛炎症和夜间β细胞死亡.
研究的目的:
- 为了研究环菲林D (Ppid) 在过度营养引起的胰岛素耐药性期间调解β细胞损失中的作用.
- 确定治疗点,以保持T2D中的β细胞质量.
主要方法:
- 使用斑马鱼胰岛素耐药模型 (zMIR),对Ppid.进行基因操纵.
- 使用的Ppid抑制剂环素A (CsA),线粒体ROS清理器线粒体TEMPO和线粒体化剂Ru360.
- 评估了β细胞质量,小岛炎症和巨细胞招募.
主要成果:
- 环素A (CsA) 在zMIR中预防了夜间β细胞死亡.
- 针对线粒体的干预措施 (mito-TEMPO,Ru360) 保护了β细胞,涉及线粒体透性过渡孔 (mPTP).
- 全球Ppid淘汰赛保留了β细胞质量,而β细胞特异的Ppid再表达恢复并加剧了对CsA敏感的β细胞损失.
结论:
- 皮皮德作为β细胞内在的调解者,对过度营养引起的β细胞损失起作用.
- 向Ppid提供了一种潜在的治疗策略,用于在2型糖尿病中保存β细胞功能.
相关概念视频
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Hypoglycemia and Glucagon
772
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
772
Insulin: Dosing Regimen and Adverse Effects
656
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
656
Glucagon-like Receptor Agonists
818
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
818


